Literature DB >> 24285247

Christianson syndrome: spectrum of neuroimaging findings.

Thangamadhan Bosemani1, Ginevra Zanni2, Adam L Hartman3, Rony Cohen4, Thierry A G M Huisman1, Enrico Bertini2, Andrea Poretti1.   

Abstract

Christianson syndrome (CS) is caused by mutations in SLC9A6 and is characterized by severe intellectual disability, absent speech, microcephaly, ataxia, seizures, and behavioral abnormalities. The clinical phenotypes of CS and Angelman syndrome (AS) are similar. Differentiation between CS and AS is important in terms of genetic counseling. We report on two children with CS and confirmed mutations in SLC9A6 focusing on neuroimaging findings and review the available literature. Cerebellar atrophy (CA) occurs in approximately 60% of the patients with CS and develops after the age of 12 months. Hyperintense signal of the cerebellar cortex (CbC) is less common, and may be diffuse, patchy, or involve only the inferior part of the cerebellum and is best seen on coronal fluid attenuation inversion recovery images. CA and CbC-hyperintensity are not neuroimaging features of AS. In a child with the phenotype of AS, CA and/or CbC-hyperintensity are rather specific for CS and should prioritize sequencing of SLC9A6. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24285247     DOI: 10.1055/s-0033-1363091

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  9 in total

1.  Syndrome of X linked intellectual disability, epilepsy, progressive brain atrophy and large head associated with SLC9A6 mutation.

Authors:  Hansashree Padmanabha; Arushi Gahlot Saini; Jitendra Kumar Sahu; Pratibha Singhi
Journal:  BMJ Case Rep       Date:  2017-12-22

Review 2.  Genetic control of postnatal human brain growth.

Authors:  Laura I van Dyck; Eric M Morrow
Journal:  Curr Opin Neurol       Date:  2017-02       Impact factor: 5.710

3.  Assorted dysfunctions of endosomal alkali cation/proton exchanger SLC9A6 variants linked to Christianson syndrome.

Authors:  Alina Ilie; Annie Boucher; Jaeok Park; Albert Marinus Berghuis; R Anne McKinney; John Orlowski
Journal:  J Biol Chem       Date:  2020-04-10       Impact factor: 5.157

4.  Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments.

Authors:  Mallory Kerner-Rossi; Maria Gulinello; Steven Walkley; Kostantin Dobrenis
Journal:  Neurobiol Learn Mem       Date:  2018-05-14       Impact factor: 2.877

5.  A Christianson syndrome-linked deletion mutation (∆(287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death.

Authors:  Alina Ilie; Andy Y L Gao; Jonathan Reid; Annie Boucher; Cassandra McEwan; Hervé Barrière; Gergely L Lukacs; R Anne McKinney; John Orlowski
Journal:  Mol Neurodegener       Date:  2016-09-02       Impact factor: 14.195

6.  Christianson syndrome: A novel splicing variant of SLC9A6 causes exon skipping in a Chinese boy and a literature review.

Authors:  Xiaoge Zhang; Xiaofang Wu; Hongli Liu; Tingting Song; Yongsheng Jiang; Hanhan He; Shaoqing Yang; Yun Xie
Journal:  J Clin Lab Anal       Date:  2021-11-17       Impact factor: 2.352

Review 7.  An inside job: how endosomal Na(+)/H(+) exchangers link to autism and neurological disease.

Authors:  Kalyan C Kondapalli; Hari Prasad; Rajini Rao
Journal:  Front Cell Neurosci       Date:  2014-06-23       Impact factor: 5.505

8.  Mixed Neurodevelopmental and Neurodegenerative Pathology in Nhe6-Null Mouse Model of Christianson Syndrome.

Authors:  Meiyu Xu; Qing Ouyang; Jingyi Gong; Matthew F Pescosolido; Brandon S Pruett; Sasmita Mishra; Michael Schmidt; Richard N Jones; Ece D Gamsiz Uzun; Sofia B Lizarraga; Eric M Morrow
Journal:  eNeuro       Date:  2018-01-17

9.  Functional Assessment In Vivo of the Mouse Homolog of the Human Ala-9-Ser NHE6 Variant.

Authors:  Qing Ouyang; Lena Joesch-Cohen; Sasmita Mishra; Hasib A Riaz; Michael Schmidt; Eric M Morrow
Journal:  eNeuro       Date:  2019-12-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.